HTB homepage • Conference reports • Articles by subject • Subscribe August 2019 Contents Editorial HTB 23 August 2019 online: second reports from IAS 2019 Special reports Fit for purpose: antiretroviral treatment optimisation July 2019 Conference reports 10th IAS Conference on HIV Science (IAS 2019) in Mexico City Four days on, three days off is NOT as effective as daily ART: French study results need to be interpreted with caution Switching to bictegravir/F/TAF in virally suppressed participants – including analyses by baseline drug resistance Dolutegravir-based first-line non-inferior to efavirenz-based ART but associated with substantial weight gain: results from the ADVANCE study Dolutegravir for younger children: results from the ODYSSEY trial PK advantages of TAF/FTC over TDF/FTC for HIV PrEP might compensate for low adherence: sub-analysis of DISCOVER study Antiretrovirals Cabotegravir/rilpivirine long-acting injectable HIV drugs submitted to EMA PDFs 23 August 2019 vol 20 no 10 HTB homepage • Conference reports • Articles by subject • Subscribe
